Therapeutic Potential of Lebrikizumab in the Treatment of Atopic Dermatitis

BACKGROUND: Atopic dermatitis (AD) is a chronic, relapsing skin condition with a wide disease spectrum. Moderate-to-severe cases often need systemic treatment. Conventional immunosuppressants have extensive side effect profiles and require close monitoring. In recent decades, there has been increasi...

Descripción completa

Detalles Bibliográficos
Autores principales: Loh, Tiffany Y, Hsiao, Jennifer L, Shi, Vivian Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023853/
https://www.ncbi.nlm.nih.gov/pubmed/32104006
http://dx.doi.org/10.2147/JAA.S211032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023853/
https://www.ncbi.nlm.nih.gov/pubmed/32104006
http://dx.doi.org/10.2147/JAA.S211032

Ejemplares similares